Collplant Biotechnologies Ltd (CLGN)

May 31, 2025

CollPlant Biotechnologies shares slide after announces capital raise of $3.6M through registered direct offering - MSN

May 31, 2025

May 31, 2025

CollPlant Biotechnologies First Quarter 2025 Earnings: Misses Expectations - simplywall.st

May 31, 2025

May 30, 2025

Dow Edges Higher; Dell Shares Fall After Q1 Results - Benzinga

May 30, 2025

May 30, 2025

CollPlant Biotechnologies Launches Share Offering; Stock Drops - marketscreener.com

May 30, 2025

May 30, 2025

CollPlant Biotechnologies (CLGN) Rating and Price Target Analysis | CLGN Stock News - GuruFocus

May 30, 2025

May 30, 2025

CollPlant (CLGN) Announces $3.6M Direct Offering and Private Placement - GuruFocus

May 30, 2025

May 30, 2025

CollPlant (CLGN) Announces New Share and Warrant Sale Agreement - GuruFocus

May 30, 2025

May 30, 2025

CollPlant (CLGN) Announces New Share and Warrant Sale Agreement | CLGN Stock News - GuruFocus

May 30, 2025

May 30, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRE - GuruFocus

May 30, 2025

May 30, 2025

CollPlant announces $3.6 million stock offering By Investing.com - Investing.com India

May 30, 2025

May 30, 2025

CollPlant announces $3.6 million stock offering - Investing.com Australia

May 30, 2025

May 30, 2025

CollPlant Raises $3.6M to Advance AbbVie Partnership and Breakthrough Regenerative Medicine Programs - Stock Titan

May 30, 2025

May 29, 2025

CollPlant Biotechnologies (NASDAQ:CLGN) Price Target Lowered to $12.00 at D. Boral Capital - Defense World

May 29, 2025

May 29, 2025

CollPlant Biotechnologies Reports Strong Q1 2025 Results - TipRanks

May 29, 2025

May 28, 2025

Collplant Biotechnologies Ltd reports results for the quarter ended March 31Earnings Summary - TradingView

May 28, 2025

May 28, 2025

CollPlant Biotechnologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 28, 2025

May 28, 2025

CollPlant Biotechnologies (CLGN) Analyst Ratings Update | CLGN S - GuruFocus

May 28, 2025

May 28, 2025

CollPlant Biotechnologies (CLGN) Analyst Ratings Update | CLGN Stock News - GuruFocus

May 28, 2025

May 28, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL R - GuruFocus

May 28, 2025

May 28, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE | CLGN Stock News - GuruFocus

May 28, 2025

May 28, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - PR Newswire

May 28, 2025

May 28, 2025

CollPlant Biotechnologies (CLGN) Expected to Announce Quarterly Earnings on Wednesday - Defense World

May 28, 2025

May 27, 2025

Earnings Preview: CollPlant Biotechnologies - Nasdaq

May 27, 2025

May 27, 2025

Global Tissue Engineering Market Insights & Industry Outlook | - openPR.com

May 27, 2025

May 22, 2025

When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Breakeven? - simplywall.st

May 22, 2025

May 14, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINAN - GuruFocus

May 14, 2025

May 14, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS - Financial Times

May 14, 2025

May 09, 2025

Renaissance Technologies LLC Acquires New Stake in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World

May 09, 2025

May 08, 2025

Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation - Yahoo Finance

May 08, 2025

Apr 24, 2025

CLGNCollplant Biotechnologies Ltd Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 24, 2025

Collplant stock hits 52-week low at $2.14 amid market challenges - Investing.com India

Apr 24, 2025

Apr 23, 2025

Collplant stock hits 52-week low at $2.14 amid market challenges By Investing.com - Investing.com South Africa

Apr 23, 2025

Apr 15, 2025

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevan - GuruFocus

Apr 15, 2025

Apr 15, 2025

FDA Animal Testing Phase-Out: How CollPlant's BioInk Tech Could Revolutionize Drug Safety Studies - Stock Titan

Apr 15, 2025

Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges - Investing.com India

Apr 03, 2025

Mar 30, 2025

CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at D. Boral Capital - The AM Reporter

Mar 30, 2025

Mar 29, 2025

D. Boral Capital Reaffirms “Buy” Rating for CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 29, 2025

Mar 28, 2025

Collplant plans clinical trials for dermal filler and advances regenerative implants - MSN

Mar 28, 2025

Mar 27, 2025

CollPlant Biotechnologies (CLGN) to Release Earnings on Thursday - Defense World

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highl - GuruFocus

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Decline in Short Interest - Defense World

Mar 27, 2025

Mar 27, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - StreetInsider.com

Mar 27, 2025

Mar 27, 2025

Earnings call transcript: Collplant Biotechnologies Q4 2024 misses forecasts - Investing.com India

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Reports 2024 Financial Results - TipRanks

Mar 27, 2025

Mar 26, 2025

CollPlant’s Earnings Call: Mixed Outlook Amid Innovations - TipRanks

Mar 26, 2025

Mar 26, 2025

SEC Form 20-F filed by CollPlant Biotechnologies Ltd - Quantisnow

Mar 26, 2025

Mar 26, 2025

Collplant Biotechnologies Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings - GuruFocus

Mar 25, 2025